During the past decade, Mercy Clinic Oklahoma Communities Inc-Norman conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Clinic Oklahoma Communities Inc-Norman" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Clinic Oklahoma Communities Inc-Norman" are "Colorectal Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Mercy Clinic Oklahoma Communities Inc-Norman" in a lesser frequency.

Most popular intervention types in "Mercy Clinic Oklahoma Communities Inc-Norman" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "celecoxib" (2 trials), "placebo" (2 trials), "5-fluorouracil" (1 trials), "carboplatin" (1 trials) and "gemcitabine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Clinic Oklahoma Communities Inc-Norman" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Clinic Oklahoma Communities Inc-Norman". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mercy Clinic Oklahoma Communities Inc-Norman, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Clinic Oklahoma Communities Inc-Norman, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".